Mar 3, 2026 08:00AM

Mar 3, 2026 08:00AM

Dec 9, 2025 07:00AM

Sep 9, 2025 07:00AM

Jul 23, 2025 08:01AM

Jul 23, 2025 08:00AM

Jul 14, 2025 04:00PM Cognyte approves $20 million share repurchase program

Jul 14, 2025 04:00PM

Jun 11, 2025 07:00AM

May 21, 2025 09:00AM

May 21, 2025 09:00AM

Apr 2, 2025 07:00AM

Dec 11, 2024 07:00AM

Nov 12, 2024 07:44AM Cognyte Software (CGNT) Announces Board Authorization of $20 Million Share Repurchase Program

Nov 12, 2024 07:44AM

Sep 10, 2024 07:00AM

Jun 18, 2024 07:00AM

Apr 9, 2024 07:00AM

Dec 13, 2023 07:00AM

Sep 12, 2023 07:00AM

Jun 15, 2023 07:00AM Cognyte Announces First Quarter Fiscal 2024 Results

Apr 11, 2023 07:00AM

Mar 12, 2023 09:00PM

Dec 20, 2022 07:00AM

Sep 28, 2022 07:00AM

Aug 26, 2022 09:00PM

Aug 5, 2022 09:00PM

Jul 31, 2022 09:00PM Bragar Eagel & Squire, P.C. Is Investigating NIO, Generac, Cognyte, and TD and Encourages Investors to Contact the Firm

Jul 25, 2022 09:00PM

Jul 15, 2022 09:00PM

Jun 28, 2022 07:00AM

Apr 5, 2022 07:00AM

Dec 21, 2021 07:30AM

Sep 20, 2021 07:30AM

Jun 22, 2021 07:30AM Cognyte Starts as a Separate Public Company with Strong First Quarter Results

Apr 29, 2021 08:24AM

Mar 31, 2021 04:05PM

Apr 23, 2018 09:30AM

Apr 23, 2018 07:02AM

Apr 21, 2018 10:00AM

Mar 26, 2018 06:16AM

Mar 21, 2018 05:29PM Form SC 13D COGENTIX MEDICAL INC Filed by: Camden Merger Sub, Inc.

Mar 12, 2018 05:22PM

Mar 12, 2018 08:50AM

Mar 12, 2018 08:50AM

Mar 12, 2018 08:49AM

Nov 7, 2017 04:01PM

Oct 6, 2017 02:17AM

Sep 28, 2017 04:05PM Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder

Jul 26, 2017 07:06AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All